MnxCe1-xO2／γ-Al2O3催化剂的制备及其催化甲苯的燃烧性能

以γ-Al2O3为载体,以MnxCe1-xO2为催化活性组分,采用浸渍法制备了一系列负载型MnxCe1-xO2／γ-Al2O3催化剂（x=0、0．2、0．4、0．6、0．8、0．9、1）,在固定床反应器中评价了催化剂对甲苯的催化燃烧性能。结果表明,MnxCe1-xO2／γ-Al2O3催化剂的催化活性与催化剂的焙烧温度、活性组分MnxCe1-xO2的负载量以及Mn、Ce摩尔比有显著关系,其中焙烧温度550℃、负载量为20％、Mn、Ce摩尔比为4：1时,即MnxCe1-xO2／γ-Al2O3催化剂对甲苯的催化性能最佳,反应温度为180℃时,甲苯的转化率达到95％。并在连续100h的稳定性操作后,催化剂的活性基本无变化。采用XRD、BET以及SEM等分析测试手段对催化剂的结构以及表面进行了表征。     

Photodegradation of quinestrol in waters and the transformation products by UV irradiation

Quinestrol is synthetic estrogen used in contraceptive and hormone replacement therapy and occasionally for treating breast cancer and prostate cancer. It can make its way into the environment through sewage discharge and waste disposal produced by human excretions. In this study, the photodegradation kinetics of quinestrol in various conditions was investigated by UV and solar irradiation. The affecting factors were studied including concentration of hydrogen peroxide, different water types, and the initial concentrations of quinestrol. Concurrently, the transformation products and presumed pathways of quinestrol in distilled water by UV irradiation were identified and proposed. The results showed that the degradation of quinestrol in both irradiation conditions followed the pseudo-first-order kinetics. More rapid degradation was observed by UV irradiation (k = 0.018 min⁻¹) than solar irradiation (k = 0.004 h⁻¹), and the photodegradation rate of quinestrol depended on the concentration of hydrogen peroxide, the initial concentration of quinestrol and water types. The transformation products of quinestrol in distilled water were identified by gas chromatography/mass spectrometry. When exposed to UV irradiation, quinestrol in aqueous solution was rapidly degraded, giving at least ten photodegradation products. The chemical structures of ten degradation products were identified on the basis of mass spectrum interpretation and literature data.     

1，4-二氯苯降解菌的分离及其降解特性研究

从某污水处理曝气池的活性污泥中分离出一株能够以1,4-二氯苯为唯一碳源和能源生长的菌株DEB-1,通过形态特征和生理生化试验初步鉴定为黄杆菌属（Flavobacterium sp.）。实验结果表明,该菌株最适降解温度为32℃、最适降解pH为7.8,24 h对100 mg/L的1,4-二氯苯的降解率达94.5%。菌株DEB-1的降解谱较广,对5种氯苯类物质具有较高的降解率。并进一步研究了DEB-1的1,4-二氯苯降解酶粗酶液的性质,其最适反应温度和pH分别为30℃和8.5。对处理含氯代芳香化合物的有机废水具有一定的意义。     

苦土和氧化镁处理氮磷废水的对比研究

分别采用苦土、纯氧化镁为沉淀剂对模拟高浓度氮磷废水(N/P=0.8)进行了脱氮除磷研究,比较了沉淀剂投加量、pH对2种沉淀剂处理氮磷废水的影响,对沉淀产物进行XRD分析,并进行了经济效益比较。结果表明,pH是影响2种沉淀剂处理氮磷废水的主要因素,随着pH的增加,脱氮除磷效果提高,在平衡pH为9～10之间时氮磷处理效果最佳,pH继续增加,由于磷酸镁沉淀的形成使得氨氮去除率降低。此外,处理相同的废水,苦土的最佳投加量要大于纯氧化镁,但是经济效益比较结果表明,以苦土为沉淀剂处理氮磷废水可大大降低处理成本。     

污泥转移SBR工艺处理低浓度生活污水

污泥转移SBR工艺是一种通过内部污泥回流实现污泥在不同SBR隔室间转移,从而增加污泥利用效率,提高系统除污效能的新工艺。以设计规模为240 m3/d、处理低浓度生活污水的工艺系统为对象,研究了新工艺在不同泥转移量(污泥回流比)下的除污性能,并与系统以传统SBR方式运行的情况进行了对比。结果表明,新工艺可以有效提高SBR反应器的容积利用率;采用30%的污泥回流比进行污泥转移,新工艺的处理能力比传统SBR工艺提高近1/2,除磷效率从46%提升至85%。出水各项水质指标均能达到国家排放标准的要求。     

鲢鱼放养控制北京城市河湖水华试验研究

介绍了利用鲢鱼控制北京城市河湖水华的试验研究,通过不同放养密度(0、17、51和103 g/m3)的现场围隔试验,对鲢鱼放养对水体水质和浮游生物的影响进行了分析.研究结果表明,鲢鱼放养使有鱼围隔中浮游生物量极低,从而使浮游植物基本不受浮游动物影响,而直接受鱼类影响;同时,中等密度(51 g/m3)的鲢鱼放养使水华蓝藻和微小藻的生长均得到了有效抑制,使藻类生物量最低.     

水葫芦厌氧发酵工程化应用研究

在实验室进行了接种率、破碎程度和温度等对水葫芦厌氧发酵产气率的影响研究.结果表明:水葫芦在中温35℃下,水葫芦和接种污泥的最佳接种率为1:1(总固体物质比),经简单切分后产气率最高,原料产气率为0.540 m3/d(以每千克固体含量计,下同);高温消化与中温消化相比,产气率无明显优势.在实验室研究基础上,对中国农村地区原有的沼气发酵工艺进行适当的改进,设计构建了5 m3 15 m3(酸化池 产气池)两级反应池,该反应池在夏季常温条件下运行良好,80 d的平均原料产气率达0.305 m3/d.     

酸雨和SO2对蔬菜生长和产量的影响

应用开顶式熏气装置,以油菜和白菜为材料,分别将其暴露于模拟酸雨(pH2.8—5.6)和模拟酸雨与0.1ppmSO_2环境中,测定单独污染与复合污染对蔬菜生长反应和产量的影响。结果表明,酸雨(pH2.8)和酸雨(pH4.6)与0.1ppmSO_2复合处理均对LAR有明显抑制,LAR最多可减少37.5%。模拟酸雨(pH2.8,3.6)使蔬菜减产1.4—8.7%,而模拟酸雨与SO_2复合污染可使蔬菜产量减少7.9—28.9%(P<0.05)。     

合肥台CTS-1分析系统网络组建

本文阐述了利用UNIX和WIN98/2000互联的局域网技术,对CTS-1系统进行优化配置,组建CTS-1网络分析系统,实现CTS-1系统数据共享,提高地震分析的效率,确保数据备份。利用代理软件用一个MODEM让各个子机同时上网,同时充分利用台站现有的计算机设备,最大限度的实现地震监控、速报、分析以及地震研究的同时开展。     

The legal frameworks that govern fetal surgery in the United Kingdom,European Union,and the United States

The specialty of fetal surgery or fetal intervention is one of the most exciting emerging fields of modern medicine. It is made possible by decades of major developments in antenatal imaging, obstetric anaesthesia, fetal medicine, paediatric surgery, and of course by the bold and novel practitioners willing to take new steps to advance the field. Beginning in the 1970s, it has now reached a stage of maturity where there are several established in utero procedures and countless clinical trials and studies to develop more. But what is the legal situation that fetal surgeons find themselves in? What are the rights and legal protections for the fetus and the mother, both of which are arguably the patient? This article will address this question, discussing and summarising the current legal frameworks governing fetal surgery in the jurisdictions of the United Kingdom, European Court of Human Rights, and the United States of America as well as discuss what the future may hold and how researchers and physicians in the specialty can best navigate the legal environment.